Comparative study on ovarian activity, cycle stability and tolerance during administration of two low-dose oral contraceptives;Ovarielle Aktivitat, Zyklusverhalten und Vertraglichkeit bei niedrigdosierten oralen Kontrazeptiva: Eine Vergleichsstudie

Zentralblatt fur Gynakologie

Volumn 119, Issue 11, 1997, Pages 538-544

  Rossmanith, W G ^a,d   Wirth, Ulrike ^a   Gasser, Susanne ^b   Thun, Barbara ^b   Steffens, Doris ^c  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b Inst F Medizinische Forschung   (Germany)

^c GRÜNENTHAL GMBH   (Germany)

^d Deutschen Multizentrischen V ^*  (Germany)

Author keywords

Gonadotropins, follicular growth; Menstrual cycle; Oral contraception; Tolerance; Vaginal sonography

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; ESTRADIOL; ETHINYLESTRADIOL PLUS NORETHISTERONE; EVE 20; ORAL CONTRACEPTIVE AGENT; UNCLASSIFIED DRUG; DESOGESTREL; ETHINYLESTRADIOL; NORETHISTERONE; SEX HORMONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE ACTION; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MULTICENTER STUDY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; RANDOMIZED CONTROLLED TRIAL; ULTRASOUND; UTERINE CERVIX; BLOOD; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; OVARIAN FUNCTION TEST; OVARY;

ADULT; CONTRACEPTIVES, ORAL, SYNTHETIC; DESOGESTREL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ETHINYL ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HUMANS; MENSTRUAL CYCLE; NORETHINDRONE; OVARIAN FUNCTION TESTS; OVARY;

EID: 0030844112     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Akerlund M, Rode A, Westergaard J: Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 μg desogestrel and either 30 μg or 20 μg ethinyl oestradiol. Brit J Obstet Gynecol 100 (1993) 832-838
2. Brill K, Schnitker J, Albring M: Clinical experience with a modern low-dose gestodene-containing oral contraceptive in adolescents. Adv Contracept 10 (1994) 237-247
3. Caillouette JC, Koehler AL: Phasic contraceptive pills and functional ovarian cysts. Am J Obstet Gynecol 156 (1987) 1538-1542
4. Fitzgerald C, Feichtinger W, Spona J, Elstein M, Ludicke F, Muller U, Williams C: A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation. Adv Contraception 10 (1994) 5-18
5. Fruzzetti F, Ricci C, Nicoletti I, Fioretti P: Clinical and metabolic effects of a triphasic pill containing gestodene. Contraception 46 (1992) 335-347
6. Grimes DA, Godwin AJ, Rubin A, Smith JA, Lacarra M: Ovulation and follicular development associated with three low-dose oral contraceptives: a randomized controlled trial. Obstet Gynecol 83 (1994) 29-34
7. Hoogland HJ, Skouby SO: Ultrasound evaluation of ovarian activity under oral contraceptives. Contraception 47 (1993) 583-590
8. Insler V, Melmed H, Ser D, Lunenfeld B: The cervical score. Int J Gynecol Obstet 10 (1972) 223-227
9. Kafrissen ME: A norgestimate-containing oral contraceptive: review of clinical studies. Am J Obstet Gynecol 167 (1992) 1196-1202
10. Kekkonen R, Lahteenmaki P, Luukkainen T, Tuominen J: Sequential regimen of the antiprogesterone RU 486 and synthetic progestin for contraception. Fertil Steril 60 (1993) 610-615
11. Killick SR, Eyong E, Elstein M: Ovarian follicular development in oral contraceptive cycles. Fertil Steril 48 (1987) 409-413
12. Kuhl H: Aktuelle Entwicklung in der hormonalen Kontrazeption. Gynäkologe 25 (1992) 231-240
13. Leidenberger F: Hormonale Kontrazeption. In: Klinische Endokrinologie für Frauenärzte. Hrss.: Leidenberger F, Heidelberg: Springer 1992, 369-411
14. Mogavero G, Sheth S, Hamper UM: Endovaginal sonography of the nongravid uterus. Radiographics 13 (1993) 969-981
15. Rossmanith WG, Wirth U, Benz R, Wolf AS: Endocrine dynamics during pulsatile GnRH administration in patients with hypothalamic amenorrhea and polycystic ovarian disease. Gynecol Endocrinol 3 (1989) 21-34
16. Silberstein SD, Merriam GR: Sex hormones and headache. J Pain Symptom Manage 8 (1993) 98-114
17. Taubert H, Kuhl H: Einfluß synthetischer Sexualsteroide auf die reproduktiven Funktionen. In: Kontrazeption mit Hormonen. Hrsg.: Taubert H, Kuhl H. Stuttgart: Thieme 1995, 120-143
18. Taubert H, Kuhl H: Hormonale Kontrazeptiva. In: Kontrazeption mit Hormonen. Hrsg.: Taubert H, Kuhl H. Stuttgart: Thieme 1995, 144-185
19. Van der Does J, Exalto N, Dieben T, Coelingh Bennink H: Ovarian activity suppression by two different tow-dose triphasic oral contraceptives. Contraception 52 (1995) 357-361
20. Van Dierendonck B, Ekwempu CC, Ladipo OP, Ulasi JN, Giwa-Osagi Oe: A multicenter clinical trial in Nigeria with a low-dose oral contraceptive, Marvelon. Adv Contracept 9 (1991) 25-32
21. Wenzl HC, Bennink A van Beek, Spona J, Huber J: Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol. Fertil Steril 60 (1993) 616-619
22. Young RL, Snabes AN, Frank ML, Reill M: A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development. Am J Obstet Gynecol 167 (1992) 678-682